Carson Wealth (CWM LLC)
RPRX icon

Carson Wealth (CWM LLC)’s Royalty Pharma RPRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Buy
46,861
+28,125
+150% +$1.23M 0.01% 1152
2025
Q4 		$724K Buy
18,736
+145
+0.8% +$5.53K ﹤0.01% 1687
2025
Q3 		$656K Buy
18,591
+281
+2% +$10.2K ﹤0.01% 1643
2025
Q2 		$660K Sell
18,310
-2,307
-11% -$76.4K ﹤0.01% 1471
2025
Q1 		$642K Buy
20,617
+11,883
+136% +$377K ﹤0.01% 1353
2024
Q4 		$223K Buy
8,734
+3,261
+60% +$86.5K ﹤0.01% 1761
2024
Q3 		$155K Sell
5,473
-1,590
-23% -$44K ﹤0.01% 1900
2024
Q2 		$186K Sell
7,063
-658
-9% -$18.2K ﹤0.01% 1626
2024
Q1 		$234K Buy
7,721
+925
+14% +$27.3K ﹤0.01% 1445
2023
Q4 		$191K Buy
6,796
+2,014
+42% +$55.3K ﹤0.01% 1441
2023
Q3 		$130K Buy
4,782
+2,064
+76% +$61.3K ﹤0.01% 1496
2023
Q2 		$84K Buy
2,718
+638
+31% +$21.6K ﹤0.01% 1661
2023
Q1 		$75K Buy
2,080
+526
+34% +$19.5K ﹤0.01% 1644
2022
Q4 		$61K Sell
1,554
-285
-15% -$11.9K ﹤0.01% 1625
2022
Q3 		$74K Sell
1,839
-418
-19% -$17.9K ﹤0.01% 1480
2022
Q2 		$95K Sell
2,257
-4,745
-68% -$195K ﹤0.01% 1336
2022
Q1 		$273K Buy
7,002
+2,680
+62% +$105K ﹤0.01% 920
2021
Q4 		$172K Buy
+4,322
New +$168K ﹤0.01% 1089
2021
Q2 		$1K Hold
15
– – ﹤0.01% 2841
2021
Q1 		$1K Hold
15
– – ﹤0.01% 2841
2020
Q4 		$1K Hold
15
– – ﹤0.01% 2841
2020
Q3 		$1K Hold
15
– – ﹤0.01% 2839
2020
Q2 		$1K Buy
+15
New +$742 ﹤0.01% 2839

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RPRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Royalty Pharma (RPRX) stake by 150% in Q1 2026, buying an estimated $1.23M and bringing the position to 46,861 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #1152.

Carson Wealth (CWM LLC) first reported a position in RPRX in Q2 2020 and has held it in 23 quarters since. 591 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 46,861 shares of Royalty Pharma worth $2.25M as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 28,125 Royalty Pharma shares in Q1 2026, an estimated $1.23M.
  • Royalty Pharma made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1152 holding.
  • Carson Wealth (CWM LLC) first reported a position in Royalty Pharma in Q2 2020 and has held it in 23 quarters since.
  • 591 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.